Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
ROCK1 promotes B cell differentiation and proteostasis under stress through the heme-regulated proteins, BACH2 and HRI
Juan Rivera-Correa, Sanjay Gupta, Edd Ricker, Danny Flores-Castro, Daniel Jenkins, Stephen Vulcano, Swati P. Phalke, Tania Pannellini, Matthew M. Miele, Zhuoning Li, Nahuel Zamponi, Young-Bum Kim, Yurii Chinenov, Eugenia Giannopoulou, Leandro Cerchietti, Alessandra B. Pernis
Juan Rivera-Correa, Sanjay Gupta, Edd Ricker, Danny Flores-Castro, Daniel Jenkins, Stephen Vulcano, Swati P. Phalke, Tania Pannellini, Matthew M. Miele, Zhuoning Li, Nahuel Zamponi, Young-Bum Kim, Yurii Chinenov, Eugenia Giannopoulou, Leandro Cerchietti, Alessandra B. Pernis
View: Text | PDF
Research Article Aging Immunology

ROCK1 promotes B cell differentiation and proteostasis under stress through the heme-regulated proteins, BACH2 and HRI

  • Text
  • PDF
Abstract

The mechanisms utilized by differentiating B cells to withstand highly damaging conditions generated during severe infections, like the massive hemolysis that accompanies malaria, are poorly understood. Here, we demonstrate that ROCK1 regulates B cell differentiation in hostile environments replete with pathogen-associated molecular patterns (PAMPs) and high levels of heme by controlling 2 key heme-regulated molecules, BACH2 and heme-regulated eIF2α kinase (HRI). ROCK1 phosphorylates BACH2 and protects it from heme-driven degradation. As B cells differentiate, furthermore, ROCK1 restrains their pro-inflammatory potential and helps them handle the heightened stress imparted by the presence of PAMPs and heme by controlling HRI, a key regulator of the integrated stress response and cytosolic proteotoxicity. ROCK1 controls the interplay of HRI with HSP90 and limits the recruitment of HRI and HSP90 to unique p62/SQSTM1 complexes that also contain critical kinases like mTOR complex 1 and TBK1, and proteins involved in RNA metabolism, oxidative damage, and proteostasis like TDP-43. Thus, ROCK1 helps B cells cope with intense pathogen-driven destruction by coordinating the activity of key controllers of B cell differentiation and stress responses. These ROCK1-dependent mechanisms may be widely employed by cells to handle severe environmental stresses, and these findings may be relevant for immune-mediated and age-related neurodegenerative disorders.

Authors

Juan Rivera-Correa, Sanjay Gupta, Edd Ricker, Danny Flores-Castro, Daniel Jenkins, Stephen Vulcano, Swati P. Phalke, Tania Pannellini, Matthew M. Miele, Zhuoning Li, Nahuel Zamponi, Young-Bum Kim, Yurii Chinenov, Eugenia Giannopoulou, Leandro Cerchietti, Alessandra B. Pernis

×

Figure 6

ROCK1 limits the assembly of p62 complexes enriched in mTORC1, ripoptosome components, and ALS-linked molecules.

Options: View larger image (or click on image) Download as PowerPoint
ROCK1 limits the assembly of p62 complexes enriched in mTORC1, ripoptoso...
Purified CD23+ B cells from WT and CD23-Rock1 mice were cultured with αIgM (5 μg/mL) + αCD40 (5 μg/mL), ± combinations of a TLR9-L (1 μg/mL) and heme (60 μM) for 3 days. (A) Western blotting analysis of the levels of p-4EBP1 in cytoplasmic extracts from WT and CD23-Rock1 B cells stimulated as indicated. (B–H) p62 was immunoprecipitated from cytoplasmic extracts of WT or CD23-Rock1 B cells stimulated as indicated. The precipitates were probed by Western blotting to assess p62 phosphorylation as well as the interaction of p62 with raptor, TRAF6, and Keap1 (B); p62 was immunoprecipitated from cytoplasmic extracts of WT or CD23-Rock1 B cells stimulated as indicated. The precipitates were probed by Western blotting to assess for the presence of phospho-TBK1, TBK1, RIPK1, and RIPK3 (C); ZBP1 (D); PLK1 (E); SOD1 and TDP-43 (G); and C9ORF72 (H). (F) Western blotting analysis of high–molecular weight p62 complexes in WT or CD23-Rock1 B cells stimulated as indicated. (I) Western blots of LC3-I and LC3-II in extracts from WT and CD23-Rock1 B cells. Cells were treated for 4 hours with DMSO or bafilomycin A1 (BafA1; 50 nM or 100 nM as indicated). All results are representative of 3 independent experiments. ALS, amyotrophic lateral sclerosis

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts